[1]
C. R. Nwizu, C. O. Nnadi, and A. C. Igboasoiyi, “Structure-Based Virtual Screening Identifies Ritobegron and Resveratrol as Dual Inhibitors of NMDA and PTP-1B for Alzheimer’s Disease Therapy”, TJPPS, vol. 5, no. 2, pp. 468–474, Apr. 2026.